3-rx.comCustomer Support3-rx.com
Find a product
    HomeAbout UsFAQContactHelp
 
   
 
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics
Online Pharmacy



Presbyopia is an eye condition in which the lens loses the ability to focus over time


Join our Mailing List

Men`s Health sites at Top100biz.com




Syndicate

You are here : 3-RX.com > Home > Drug News - Public Health - Sexual Health -

Only one drug type now knocks out gonorrhea in US

Drug News • • Public Health • • Sexual HealthApr 12, 07

Due to drug resistance, one class of antibiotics should no longer be used to treat Gonorrhea, officials with the US Centers for Disease Control and Prevention (CDC) announced Thursday.

They no longer recommend antibiotics called fluoroquinolones—which include ciprofloxacin, ofloxacin, and levofloxacin—for treatment of Gonorrhea because fluoroquinolone-resistant Gonorrhea is now widespread in the United States. 

Consequently, only one class of drugs, the cephalosporins, is still recommended and available for the treatment of Gonorrhea, Dr. John M. Douglas, Jr., of the CDC declared in a news briefing.

Since 1993, fluoroquinolones have been used widely to treat Gonorrhea, the CDC notes in its publication, the Morbidity and Mortality Weekly Report, where the new data and treatment recommendations appear.

Beginning in 2000, however, fluoroquinolones were no longer recommended for Gonorrhea infections acquired in Asia or the Pacific Islands, including Hawaii. In 2002, this recommendation was extended to California, and in 2004, the CDC recommended that these antibiotics not be used in the US to treat Gonorrhea infections in gay men.

On the basis of the most recent evidence from surveillance in 26 cities, the CDC no longer recommends the use of these drugs for the treatment of Gonorrhea in any group, anywhere in the US.

“We have reached a level of fluoroquinolone resistance that threatens our ability to treat the disease across populations,” Dr. Douglas said.

Gonorrhea is the second most commonly reported infectious disease in the US. In 2005, there were nearly 340,000 cases reported in the US, but CDC estimates that roughly twice that number of infections occur each year.

With only the cephalosporins left for treating Gonorrhea, accelerated research for new drugs, as well as increased efforts to monitor for emerging drug resistance especially to cephalosporins, is urgently needed, according to the CDC.

SOURCE: Morbidity and Mortality Weekly Report, April 13, 2007.



Print Version
Tell-a-Friend

RELATED ARTICLES:
  Cancer survival rates impact type of Web communities used by patients
  Thanksgiving food cost up 6 percent: farm group
  Older adults should be part of treatment decisions
  Families, friends, schools and neighborhoods contribute to adolescent alcohol misuse
  New European guidelines on heart attack management put emphasis on speed of action
  Staying active may lower health risks for large, retired athletes
  Experts Available to Comment on New Study about Risk of Sudden Cardiac Death
  Healthy Bones Program Reduces Hip Fractures by 37 Percent, Study Finds
  Scientists Map Molecular Regulation of Fat-Cell Genetics
  Lung Airway Cells Activate Vitamin D, Help Immunity
  Are Pediatricians Getting the Training They Need to Meet Patient Needs?
  Sexual trauma afflicts 15 percent of U.S. vets

 


Advertisement
















Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site